Charles Bonnet syndrome: Visual hallucination and multiple sclerosis

International Journal of Psychiatry in Medicine

Volumn 33, Issue 2, 2003, Pages 195-199

  Alao, Adekola O ^a,b   Hanrahan, Brian ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Charles Bonnet syndrome; Multiple sclerosis; Psychosis; Visual hallucinations

Indexed keywords

OLANZAPINE;

ADULT; ARTICLE; CASE REPORT; CHARLES BONNET SYNDROME; CLINICAL FEATURE; COGNITION; DISEASE COURSE; FEMALE; HUMAN; MINI MENTAL STATE EXAMINATION; MULTIPLE SCLEROSIS; NEUROPSYCHIATRY; OPTIC NERVE DISEASE; SPEECH INTELLIGIBILITY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL HALLUCINATION;

ADULT; FEMALE; HALLUCINATIONS; HUMANS; MULTIPLE SCLEROSIS; SYNDROME;

EID: 0141633001     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/0NUQ-Y5Q9-TA6H-RJHH     Document Type: Article

References (16)

1. Mohr DC, Cox D. Multiple sclerosis: Empirical literature for the clinical health psychologist. Journal of Clinical Psychology 2001;57:479-499.
2. Richards A, Brian C, Dillon MJ, Bailey CM, Craniometaphyseal and craniodiaphyseal dysplasia, head and neck manifestations and management. Journal of Laryngology and Otolology 1996;110:328-338.
3. Pine DS, Douglas CJ, Charles E, Davies M, Kahn D. Patients with multiple sclerosis presenting to psychiatric hospitals. Journal of Clinical Psychiatry 1995;56:297-306.
4. Stenager EN, Stenager E, Kock-Henriksen N, Bronnum-Hansen H, Hyllested K, Jensen K, Bille-Brahe V. Suicide and multiple sclerosis: An epidemiological investigation. Journal of Neurology, Neurosurgery, and Psychiatry 1992;55:542.
5. Pliskin NH, Kiolbasa TA, Towle BL, Pankow L, Ernest JT, Noronha A, et al. Charles Bonnet syndrome: Early marker for dementia? Journal of American Geriatric Society 1996;44:1055-1061.
6. Batra A, Bartels M, Wormstall H. Therapeutic options in Charles Bonnet syndrome. Acta Psychiatrica Scandinavica 1997;96:L129-L133.
7. Cogan DG. Visual hallucinations as release phenomena. Graefe's Archive for Clinical and Experimental Ophthalmology 1973;188:139-150.
8. Lepore FE. Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways. Neurology 1990;40:444-447.
9. Mojica TR, Bailey PP. Hallucinations in the vision-impaired elderly: The Charles Bonnet syndrome. Nurse Practitioner 2000;25:74-76.
10. Chen CS, Lin SF, Chong MY. Charles Bonnet syndrome and multiple sclerosis. American Journal of Psychiatry 2001;158:1158-1159.
11. Au Eong KG, Fujii GY, Ng EW, Humayun MS, Pieramici DJ, de Juan E Jr. Transient formed visual hallucinations following macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. American Journal of Ophthalmology 2001;131:664-666.
12. Alao AO, Armenta WA, Yolles J, Naprawa SA. Visual hallucination in cranio-metaphyseal dysplasia successfully treated with olanzapine. Journal of Pharmacy Technology 2000;16:241-243.
13. Fernandez A, Lichtshein G, Vieweg WV. The Charles Bonnet syndrome: A review. Journal of Nervous and Mental Disease 1997;185;195-200.
14. Bhatia MS, Khastgir U, Malik SC. Charles Bonnet syndrome. British Journal of Psychiatry 1992;161:409-410.
15. Ranen MG, Pasternak RE, Rovne BW. Cisapride in the treatment of visual hallucinations caused by vision loss: The Charles Bonnet syndrome. American Journal of Geriatric Psychiatry 1999;7:264-266.
16. Alao AO, Armenta WA, Yolles JC. High-dose olanzapine therapy in schizophrenia (letter). Annals of Pharmacotherapy 1999;33:1228.